Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer.
Sandini M, Patino M, Ferrone CR, Alvarez-Pérez CA, Honselmann KC, Paiella S, Catania M, Riva L, Tedesco G, Casolino R, Auriemma A, Salandini MC, Carrara G, Cristel G, Damascelli A, Ippolito D, D'Onofrio M, Lillemoe KD, Bassi C, Braga M, Gianotti L, Sahani D, Fernández-Del Castillo C. Sandini M, et al. Among authors: auriemma a. JAMA Surg. 2018 Sep 1;153(9):809-815. doi: 10.1001/jamasurg.2018.0979. JAMA Surg. 2018. PMID: 29801062 Free PMC article.
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma.
Maggino L, Malleo G, Marchegiani G, Viviani E, Nessi C, Ciprani D, Esposito A, Landoni L, Casetti L, Tuveri M, Paiella S, Casciani F, Sereni E, Binco A, Bonamini D, Secchettin E, Auriemma A, Merz V, Simionato F, Zecchetto C, D'Onofrio M, Melisi D, Bassi C, Salvia R. Maggino L, et al. Among authors: auriemma a. JAMA Surg. 2019 Oct 1;154(10):932-942. doi: 10.1001/jamasurg.2019.2277. JAMA Surg. 2019. PMID: 31339530 Free PMC article.
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma.
Trestini I, Paiella S, Sandini M, Sperduti I, Elio G, Pollini T, Melisi D, Auriemma A, Soldà C, Bonaiuto C, Tregnago D, Avancini A, Secchettin E, Bonamini D, Lanza M, Pilotto S, Malleo G, Salvia R, Bovo C, Gianotti L, Bassi C, Milella M. Trestini I, et al. Among authors: auriemma a. Ann Surg Oncol. 2020 Dec;27(13):5325-5334. doi: 10.1245/s10434-020-08515-5. Epub 2020 May 9. Ann Surg Oncol. 2020. PMID: 32388740
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer.
Rossi G, Simoni N, Paiella S, Rossi R, Venezia M, Micera R, Malleo G, Salvia R, Giuliani T, Di Gioia A, Auriemma A, Milella M, Guariglia S, Cavedon C, Bassi C, Mazzarotto R. Rossi G, et al. Among authors: auriemma a. Front Oncol. 2021 Apr 20;11:662205. doi: 10.3389/fonc.2021.662205. eCollection 2021. Front Oncol. 2021. PMID: 33959509 Free PMC article.
Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma.
Cereda S, Milella M, Cordio S, Leone F, Aprile G, Galiano A, Mosconi S, Vasile E, Santini D, Belli C, Auriemma A, Novarino A, Vaccaro V, Martines C, Marino D, Lutrino SE, Palazzo V, Reinach B, Aldrighetti L, Reni M. Cereda S, et al. Among authors: auriemma a. Cancer Chemother Pharmacol. 2016 Jan;77(1):109-14. doi: 10.1007/s00280-015-2919-0. Epub 2015 Dec 10. Cancer Chemother Pharmacol. 2016. PMID: 26659366 Clinical Trial.
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma.
Trestini I, Carbognin L, Peretti U, Sperduti I, Caldart A, Tregnago D, Avancini A, Auriemma A, Orsi G, Pilotto S, Frulloni L, Capurso G, Bria E, Reni M, Tortora G, Milella M. Trestini I, et al. Among authors: auriemma a. Front Oncol. 2021 Sep 9;11:688889. doi: 10.3389/fonc.2021.688889. eCollection 2021. Front Oncol. 2021. PMID: 34568019 Free PMC article.
57 results